CVC talks $4B Alvogen sale with Shanghai after just 2 years of ownership

And a sale of Alvogen’s U.S. business to Shanghai Pharmaceuticals Holding Co. is on the table. RELATED: Generics maker Alvogen eyes faster growth after CVC-led buyout CVC and its fellow controlling shareholders—who nabbed their stake in a 2015 deal …
( read original story …)

Related Post